Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model

A major obstacle to obtaining relevant results in cancer vaccination has been the lack of identification of immunogenic antigens. Dendritic cell (DC)-based cancer vaccines used preventively may afford protection against tumor inoculation, but the effect of antigen choice on anti-tumor protection is...

Descripción completa

Detalles Bibliográficos
Autores principales: Keon, Soledad Mac, Bentivegna, Sofía, Levy, Estrella M., Marks, Michael S., Mantegazza, Adriana R., Wainstok, Rosa, Mordoh, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713901/
https://www.ncbi.nlm.nih.gov/pubmed/31307876
http://dx.doi.org/10.1016/j.vaccine.2019.07.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713901/
https://www.ncbi.nlm.nih.gov/pubmed/31307876
http://dx.doi.org/10.1016/j.vaccine.2019.07.018

Ejemplares similares